Meeting
2021 ASCO Annual Meeting
The landscape of germline mutations and the relationship with tumor mutation burden in Chinese patients with lung cancer.
Authors
Jian Shi
Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Jian Shi , Rongfeng Liu , Guanglei Huang , Lixing Wang , Baoen Shan , Ningning Luo , Qin Zhang , Didi Guo , Yaqing Wu , Yingxue Qi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10522)
DOI
10.1200/JCO.2021.39.15_suppl.10522
Abstract #
10522
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares